Article info
PDFSpecial populations
Original research
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
- Correspondence to prof Natale Daniele Brunetti, Department of Medical & Surgical Sciences, Università degli Studi di Foggia, Foggia 71122, Italy; nd.brunetti{at}unifg.it
Citation
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Publication history
- Received April 22, 2021
- Accepted August 30, 2021
- First published October 5, 2021.
Online issue publication
August 01, 2023
Article Versions
- Previous version (1 August 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage